Adenosine and autism: a spectrum of opportunities

Neuropharmacology. 2013 May:68:116-21. doi: 10.1016/j.neuropharm.2012.08.013. Epub 2012 Aug 24.

Abstract

In rodents, insufficient adenosine produces behavioral and physiological symptoms consistent with several comorbidities of autism. In rodents and humans, stimuli postulated to increase adenosine can ameliorate these comorbidities. Because adenosine is a broad homeostatic regulator of cell function and nervous system activity, increasing adenosine's influence might be a new therapeutic target for autism with multiple beneficial effects. This article is part of the Special Issue entitled 'Neurodevelopmental Disorders'.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Adenosine / metabolism*
  • Animals
  • Autistic Disorder / metabolism*
  • Humans

Substances

  • Adenosine